Panacea Biotec Limited (BOM:531349)
India · Delayed Price · Currency is INR 535.35
+1.00 (0.19%)
At close: Jun 19, 2026
Panacea Biotec Market Cap
Panacea Biotec has a market cap or net worth of 32.85 billion as of June 18, 2026. Its market cap has increased by 1.11% in one year.
Market Cap
32.85B
Enterprise Value
31.69B
Revenue
6.40B
Ranking
n/a
PE Ratio
n/a
Stock Price
535.35
Market Cap Chart
Since April 1, 2002, Panacea Biotec's market cap has increased from 21.08B to 32.85B, an increase of 55.89%. That is a compound annual growth rate of 1.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 32.85B | 42.55% |
| Dec 31, 2025 | 23.05B | -10.11% |
| Dec 31, 2024 | 25.64B | 149.32% |
| Dec 29, 2023 | 10.28B | 18.20% |
| Dec 30, 2022 | 8.70B | -28.49% |
| Dec 31, 2021 | 12.17B | -17.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Drugs | 33.84B |
| Titan Biotech | 17.94B |
| Hester Biosciences | 17.67B |
| CCME Global | 5.12B |
| Zenotech Laboratories | 2.71B |
| Bharat Immunologicals & Biologicals Corporation | 750.47M |
| Transgene Biotek | 239.43M |
| Hindustan Bio Sciences | 81.70M |